JP2010536821A5 - - Google Patents

Download PDF

Info

Publication number
JP2010536821A5
JP2010536821A5 JP2010521405A JP2010521405A JP2010536821A5 JP 2010536821 A5 JP2010536821 A5 JP 2010536821A5 JP 2010521405 A JP2010521405 A JP 2010521405A JP 2010521405 A JP2010521405 A JP 2010521405A JP 2010536821 A5 JP2010536821 A5 JP 2010536821A5
Authority
JP
Japan
Prior art keywords
methyl
piperazin
benzamide
tert
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010521405A
Other languages
English (en)
Japanese (ja)
Other versions
JP5444547B2 (ja
JP2010536821A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/060788 external-priority patent/WO2009024550A1/en
Publication of JP2010536821A publication Critical patent/JP2010536821A/ja
Publication of JP2010536821A5 publication Critical patent/JP2010536821A5/ja
Application granted granted Critical
Publication of JP5444547B2 publication Critical patent/JP5444547B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010521405A 2007-08-20 2008-08-18 Lxr調節因子としてのn−ベンジル,n’−アリールカルボニルピペラジン誘導体 Expired - Fee Related JP5444547B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07114602 2007-08-20
EP07114602.1 2007-08-20
PCT/EP2008/060788 WO2009024550A1 (en) 2007-08-20 2008-08-18 N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators

Publications (3)

Publication Number Publication Date
JP2010536821A JP2010536821A (ja) 2010-12-02
JP2010536821A5 true JP2010536821A5 (enExample) 2013-12-05
JP5444547B2 JP5444547B2 (ja) 2014-03-19

Family

ID=40032504

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010521405A Expired - Fee Related JP5444547B2 (ja) 2007-08-20 2008-08-18 Lxr調節因子としてのn−ベンジル,n’−アリールカルボニルピペラジン誘導体

Country Status (12)

Country Link
EP (1) EP2190827B1 (enExample)
JP (1) JP5444547B2 (enExample)
CN (1) CN101848899B (enExample)
AR (1) AR067975A1 (enExample)
AT (1) ATE495161T1 (enExample)
CA (1) CA2694604C (enExample)
CL (1) CL2008002429A1 (enExample)
DE (1) DE602008004562D1 (enExample)
MX (1) MX2010001847A (enExample)
PE (1) PE20091241A1 (enExample)
TW (1) TW200922582A (enExample)
WO (1) WO2009024550A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8314091B2 (en) 2007-08-20 2012-11-20 Msd Oss B.V. N-benzyl,N'-arylcarbonylpiperazine derivatives
TW201022230A (en) * 2008-08-28 2010-06-16 Organon Nv 1-(4-ureidobenzoyl)piperazine derivatives
KR101671046B1 (ko) * 2009-04-29 2016-10-31 코와 가부시키가이샤 헤테로환 링커를 갖는 카르비놀 화합물
US8242260B2 (en) 2009-08-28 2012-08-14 Novartis Ag Compounds and compositions as protein kinase inhibitors
WO2012033353A2 (ko) 2010-09-07 2012-03-15 서울대학교 산학협력단 세스터터핀 화합물 및 이들 물질의 용도
AU2013302861A1 (en) 2012-08-13 2015-03-05 The Rockefeller University Treatment and diagnosis of melanoma
CN103159687A (zh) * 2013-04-12 2013-06-19 苏州科捷生物医药有限公司 一种2-胺基吡嗪-5甲酸的合成方法
EP3402477A4 (en) 2016-01-11 2019-08-21 The Rockefeller University METHOD FOR THE TREATMENT OF DISEASES RELATED TO MYELOID-DERIVED SUPPRESSOR CELLS
CA3078981A1 (en) 2017-11-21 2019-05-31 Rgenix, Inc. Polymorphs and uses thereof
TWI888447B (zh) 2019-12-13 2025-07-01 美商因思博納公司 金屬鹽及其用途
WO2023240376A1 (zh) * 2022-06-12 2023-12-21 中国医学科学院药物研究所 肠道上皮细胞核受体抑制子NCoR作为靶标在筛选药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0742208A1 (en) * 1995-05-05 1996-11-13 Grelan Pharmaceutical Co., Ltd. 2-Ureido-benzamide derivatives
CA2448080A1 (en) * 2001-05-22 2002-11-28 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
SE0102764D0 (sv) * 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
FR2892722B1 (fr) * 2005-11-02 2008-08-15 Clinigenetics Sa Composes de type methanone et leur utilisation dans des compositions pharmaceutiques notamment pour le traitement des maladies cardiovasculaires
CN101309915A (zh) * 2005-11-14 2008-11-19 Irm责任有限公司 作为lxr调节剂的化合物和组合物
EP1965862A2 (en) * 2005-12-21 2008-09-10 Schering Corporation Combination of an h3 antagonist/inverse agonist and an appetite suppressant

Similar Documents

Publication Publication Date Title
JP2010536821A5 (enExample)
RU2388750C2 (ru) Ингибиторы фосфодиэстеразы 4, включая аналоги n-замещенного диариламина
RU2424240C2 (ru) Антибактериальные производные пиперидина
JP2007519754A5 (enExample)
RU2009126624A (ru) Производные 2-(пиперидин-4-ил)-4-фенокси-или фенилаинопиримидина в качестве ненуклеозидных ингибитров обратной транскриптазы
RU2000128036A (ru) Амидиновые соединения
JP2017523972A5 (enExample)
RU2009121775A (ru) Пиридильное неароматическое азот-содержащее гетероцикло-1-карбоксилатное производное
NZ590268A (en) 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
JP2007231005A5 (enExample)
RU2006135111A (ru) Производные тиазола
JP2018522823A5 (enExample)
JP2018502877A5 (enExample)
JP2013510122A5 (enExample)
JP2010538076A5 (enExample)
JP2011503103A5 (enExample)
JP2005517006A5 (enExample)
JP2014502988A5 (enExample)
AR062299A1 (es) Derivados de bencimidazol
RU2018145761A (ru) Сульфонамидное соединение или его соль
RU2010138577A (ru) ИНГИБИТОРЫ РЕЦЕПТОРА ХЕМОКИНА CxCR3
RU2013132930A (ru) Производное пиразола
JP2015522607A5 (enExample)
JP2018048143A5 (enExample)
NZ612544A (en) Heterocyclic compounds suitable for the treatment of dyslipidemia